anti-SSA Ro
Selected indexed studies
- Hydroxychloroquine to Prevent Recurrent Congenital Heart Block in Fetuses of Anti-SSA/Ro-Positive Mothers. (J Am Coll Cardiol, 2020) [PMID:32674792]
- Anti-Ro/SSA and/or anti-La/SSB antibodies are associated with adverse endometrial status. (Am J Reprod Immunol, 2023) [PMID:36181668]
- Anti-Ro/SSA and/or anti-La/SSB antibodies are associated with adverse IVF and pregnancy outcomes. (J Reprod Immunol, 2022) [PMID:34929496]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Hydroxychloroquine to Prevent Recurrent Congenital Heart Block in Fetuses of Anti-SSA/Ro-Positive Mothers. (2020) pubmed
- Anti-Ro/SSA and/or anti-La/SSB antibodies are associated with adverse endometrial status. (2023) pubmed
- Anti-Ro/SSA and/or anti-La/SSB antibodies are associated with adverse IVF and pregnancy outcomes. (2022) pubmed
- Clinical significance of anti-SSA/Ro antibody in Neuromyelitis optica spectrum disorders. (2022) pubmed
- Neonatal lupus erythematosus - practical guidelines. (2021) pubmed
- [Anti-SSA/Ro and anti-SSB/La antibodies. What's new?]. (2002) pubmed
- Neonatal lupus: Follow-up in infants with anti-SSA/Ro antibodies and review of the literature. (2017) pubmed
- Immunoassay Detects Salivary Anti-SSA/Ro-52 Autoantibodies in Seronegative Patients with Primary Sjögren's Syndrome. (2023) pubmed
- Maternal and infant outcomes of pregnancy associated with anti-SSA/RO antibodies: a systematic review and meta-analysis. (2023) pubmed
- Anti-SSA/Ro antibodies and the heart: more than complete congenital heart block? A review of electrocardiographic and myocardial abnormalities and of treatment options. (2005) pubmed